Keyword: Zurampic


AZ hands off gout drug Zurampic to Ironwood for $100M-plus

Did Ironwood Pharmaceuticals just pick up a promising product, or did AstraZeneca just unload a problematic one? You be the judge: Ironwood says it will pay up to $265 million in cash plus royalties for the chance to market AstraZeneca’s recently approved gout drug Zurampic.